Director/PDMR Shareholding

RNS Number : 6881B

GlaxoSmithKline PLC

06 March 2014

 



Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Deferred Annual Bonus Plan

Withholding of shares to meet tax liabilities

The table below sets out changes in the interests of PDMRs in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADSs at a fair market value of $55.80 per ADS to meet tax liabilities following the vesting of the post-tax awards granted under the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (DABP). Vesting of these awards was announced on 14 February 2014 following the date the Remuneration Committee determined the level of vesting. These post-tax awards formally vested on the third anniversary of the award date which was 4 March 2014. 

	Number of ADSs withheld to meet tax liabilities following the vesting of a DABP award
Ms D Connelly	123
Mr W Louv	308

The Company and the PDMRs were advised of these transactions on 5 March 2014.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

6 March 2014

 

END

 

 

RDSBQLFBZXFEBBQ